Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · BrightSpring Health Services (BTSG)

BrightSpring Health Services: Hospice President Michael McMaude resigns, moves to consulting

Neutral Impact 2 of 5 leadership Written later

BrightSpring said Michael McMaude resigned on June 20, 2025 as President of Hospice Services and as CEO of subsidiary Abode Healthcare, effective immediately, and that he is not leaving over any disagreement with the company. He will continue as a non-employee consultant through the earlier of January 26, 2027 or early termination, under a Resignation Agreement that the filing says includes stock option and equity provisions, and restrictive covenants.

Key points

  • Resigned as President of Hospice Services and CEO of Abode Healthcare, effective June 20, 2025
  • Consulting period runs until the earlier of January 26, 2027 or early termination
  • Consulting fee of $2,000 per month, plus $12,000 for the first 45 days, plus pre-approved expenses
  • Unvested options, RSUs and phantom shares keep vesting during consulting; full filing attached as Exhibit 10.1

The filing

CompanyBrightSpring Health Services (BTSG)
Form8-K, current report
Filed with the SECJun 20, 2025, 5:15 PM ET
Accession number0000950170-25-088587

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 20, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.